Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

OCS Lung System EXPAND II Trial

ClinicalTrials.gov ID: NCT03343535

Public ClinicalTrials.gov record NCT03343535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Trial to Evaluate the Safety and Effectiveness of the Portable Organ Care System (OCS™) Lung System for Recruiting, Preserving and Assessing Non-Ideal Donor Lungs for Transplantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and effectiveness of the OCS™ Lung System to recruit, preserve and assess non-ideal donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.

Study identification

NCT ID
NCT03343535
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
TransMedics
Industry
Enrollment
46 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 12, 2018 (Actual)
Primary completion
Aug 27, 2019 (Actual)
Completion
Jul 6, 2022 (Actual)
Last update posted
Feb 28, 2024

2018 – 2022

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
UCLA Medical Center Los Angeles California 90095 —
University of California, San Francisco San Francisco California 94143 —
Stanford University Medical Center Stanford California 94305 —
The Johns Hopkins Hospital Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Minnesota Minneapolis Minnesota 55455 —
University of Nebraska Omaha Nebraska 68198 —
Duke University Medical Center Durham North Carolina 27710 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Baylor St. Luke's Medical Center Houston Texas 77030 —
Houston Methodist Houston Texas 77030 —
University of Virginia Charlottesville Virginia 22908 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03343535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2024 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03343535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →